Skip to main content

HAVN Life Sciences Stock Forecast, Price & News

+0.00 (+0.40 %)
(As of 05/14/2021 03:52 PM ET)
Today's Range
50-Day Range
52-Week Range
Volume27,680 shs
Average Volume207,104 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
30 days | 90 days | 365 days | Advanced Chart
Receive HAVLF News and Ratings via Email

Sign-up to receive the latest news and ratings for HAVN Life Sciences and its competitors with MarketBeat's FREE daily newsletter.

HAVN Life Sciences logo

About HAVN Life Sciences

HAVN Life Sciences Inc., a biotechnology company, engages in the research and development of psychopharmacological products from plants and fungi. The company was founded in 2020 and is headquartered in Vancouver, Canada.


See More Headlines

Industry, Sector and Symbol

Industry Biotechnology
Phone604 359 0060
Year FoundedN/A

Sales & Book Value

Annual SalesN/A





Next Earnings DateN/A
OptionableNot Optionable


Overall MarketRank

0.00 out of 5 stars

Medical Sector

1982nd out of 2,044 stocks

Biotechnology Industry

143rd out of 158 stocks

Analyst Opinion: 0.0Community Rank: 0.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles

HAVN Life Sciences (OTCMKTS:HAVLF) Frequently Asked Questions

What stocks does MarketBeat like better than HAVN Life Sciences?

Wall Street analysts have given HAVN Life Sciences a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but HAVN Life Sciences wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting HAVN Life Sciences?

HAVN Life Sciences saw a decline in short interest during the month of April. As of April 15th, there was short interest totaling 1,400 shares, a decline of 56.3% from the March 31st total of 3,200 shares. Based on an average trading volume of 164,700 shares, the days-to-cover ratio is presently 0.0 days.
View HAVN Life Sciences' Short Interest

Who are HAVN Life Sciences' key executives?

HAVN Life Sciences' management team includes the following people:
  • Mr. Tim Moore, CEO & Director (Age 62, Pay $115.42k)
  • Mr. Eli Seamus-Sweet Dusenbury C.A., CPA, CPA, CA, Chief Financial Officer (Age 38, Pay $120.22k)
  • Ms. Jenna Pozar, Chief Operating Officer
  • Ms. Susan Chapelle, Exec. Vice-Pres of R&D
  • Mr. Gary Joseph Leong, Chief Science Officer (Age 56)
  • Dr. Ivan Casselman, Chief Psychedelics Officer
  • Mr. Alexzander Samuelsson, Chief Research Officer

Who are some of HAVN Life Sciences' key competitors?

What is HAVN Life Sciences' stock symbol?

HAVN Life Sciences trades on the OTCMKTS under the ticker symbol "HAVLF."

How do I buy shares of HAVN Life Sciences?

Shares of HAVLF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is HAVN Life Sciences' stock price today?

One share of HAVLF stock can currently be purchased for approximately $0.63.

What is HAVN Life Sciences' official website?

The official website for HAVN Life Sciences is

How can I contact HAVN Life Sciences?

The company can be reached via phone at 604 359 0060.

This page was last updated on 5/15/2021 by Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.